Literature DB >> 25473082

Discovery of functional antibodies targeting ion channels.

Trevor C I Wilkinson1, Matthew J Gardener2, Wendy A Williams2.   

Abstract

Ion channels play critical roles in physiology and disease by modulation of cellular functions such as electrical excitability, secretion, cell migration, and gene transcription. Ion channels represent an important target class for drug discovery that has been largely addressed, to date, using small-molecule approaches. A significant opportunity exists to target these channels with antibodies and alternative formats of biologics. Antibodies display high specificity and affinity for their target antigen, and they have the potential to target ion channels very selectively. Nevertheless, isolating antibodies to this target class is challenging due to the difficulties in expression and purification of ion channels in a format suitable for antibody drug discovery in addition to the complexity of screening for function. In this article, we will review the current state of ion channel biologics discovery and the progress that has been made. We will also highlight the challenges in isolating functional antibodies to these targets and how these challenges may be addressed. Finally, we also illustrate successful approaches to isolating functional monoclonal antibodies targeting ion channels by way of a number of case studies drawn from recent publications.
© 2014 Society for Laboratory Automation and Screening.

Keywords:  antigens; ion channels; monoclonal antibodies; screening

Mesh:

Substances:

Year:  2014        PMID: 25473082     DOI: 10.1177/1087057114560698

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  12 in total

1.  Generation of High-Specificity Antibodies against Membrane Proteins Using DNA-Gold Micronanoplexes for Gene Gun Immunization.

Authors:  Debra T Hansen; Felicia M Craciunescu; Petra Fromme; Stephen A Johnston; Kathryn F Sykes
Journal:  Curr Protoc Protein Sci       Date:  2018-02-21

Review 2.  Next generation antibody drugs: pursuit of the 'high-hanging fruit'.

Authors:  Paul J Carter; Greg A Lazar
Journal:  Nat Rev Drug Discov       Date:  2017-12-01       Impact factor: 84.694

Review 3.  Ion channelopathies of the immune system.

Authors:  Martin Vaeth; Stefan Feske
Journal:  Curr Opin Immunol       Date:  2018-04-07       Impact factor: 7.486

Review 4.  Nucleic Acid Aptamers: An Emerging Tool for Biotechnology and Biomedical Sensing.

Authors:  Ti-Hsuan Ku; Tiantian Zhang; Hua Luo; Tony M Yen; Ping-Wei Chen; Yuanyuan Han; Yu-Hwa Lo
Journal:  Sensors (Basel)       Date:  2015-07-06       Impact factor: 3.576

5.  Evaluation of recombinant monoclonal antibody SVmab1 binding to Na V1.7 target sequences and block of human Na V1.7 currents.

Authors:  Dong Liu; Mandy Tseng; Linda F Epstein; Lydia Green; Brian Chan; Brian Soriano; Desiree Lim; Oscar Pan; Christopher M Murawsky; Chadwick T King; Bryan D Moyer
Journal:  F1000Res       Date:  2016-11-25

6.  Analysis of the effect of promoter type and skin pretreatment on antigen expression and antibody response after gene gun-based immunization.

Authors:  Rajesh Vij; Zhonghua Lin; Kellen Schneider; Dhaya Seshasayee; James T Koerber
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240

7.  Going native: Direct high throughput screening of secreted full-length IgG antibodies against cell membrane proteins.

Authors:  Yongliang Fang; Thach H Chu; Margaret E Ackerman; Karl E Griswold
Journal:  MAbs       Date:  2017-09-21       Impact factor: 5.857

8.  Immune Response of BALB/c Mice toward Putative Calcium Transporter Recombinant Protein of Trichomonas vaginalis.

Authors:  Tahali Mendoza-Oliveros; Victor Arana-Argáez; Leidi C Alvaréz-Sánchez; Julio Lara-Riegos; María Elizbeth Alvaréz-Sánchez; Julio C Torres-Romero
Journal:  Korean J Parasitol       Date:  2019-02-26       Impact factor: 1.341

Review 9.  Ion channels as therapeutic antibody targets.

Authors:  Catherine J Hutchings; Paul Colussi; Theodore G Clark
Journal:  MAbs       Date:  2018-12-10       Impact factor: 5.857

10.  Generation and characterization of novel recombinant anti-hERG1 scFv antibodies for cancer molecular imaging.

Authors:  Claudia Duranti; Laura Carraresi; Angelica Sette; Matteo Stefanini; Tiziano Lottini; Silvia Crescioli; Olivia Crociani; Luisa Iamele; Hugo De Jonge; Ermanno Gherardi; Annarosa Arcangeli
Journal:  Oncotarget       Date:  2018-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.